BMJ4d
Age-stratified comparison of heart age and predicted cardiovascular risk in 370 000 primary care patients
Background Cardiovascular disease (CVD) preventive medications are recommended for patients at high short-term CVD risk. As most younger people with multiple raised CVD risk factors levels have low ...
BMJ1d
Assessment and classification of patients with myocardial injury and infarction in clinical practice
BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK Correspondence to Dr Andrew R Chapman, BHF Centre for Cardiovascular Science, Chancellors Building, University of ...
BMJ2d
The risk of misdiagnosis in acute thoracic aortic dissection: a review of current guidelines
Acute aortic syndrome and in particular aortic dissection (AAD) persists as a cause of significant morbidity and mortality despite improvements in surgical management. This clinical review aims to ...
BMJ3d
Chocolate consumption and risk of cardiovascular diseases: a meta-analysis of prospective studies
1 The Affiliated Luohu Hospital, Shenzhen University Health Science Center, Shenzhen, China Objective Studies investigating the impact of chocolate consumption on cardiovascular disease (CVD) have ...
BMJ6d
Clinical significance of the bicuspid aortic valve
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
BMJ6d
Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine
Department of Pharmacology, CV Therapeutics, Inc, Palo Alto, California, USA Correspondence to: Dr Luiz Belardinelli Department of Pharmacological Sciences, CV ...
BMJ2d
Use of intravenous magnesium to treat acute onset atrial fibrillation: a meta-analysis
Dr K M Ho, Intensive Care Unit, Royal Perth Hospital, Perth, WA 6000, Australia; kwok.ho{at}health.wa.gov.au Objectives: To assess the effects of intravenous magnesium on converting acute onset atrial ...
BMJ4d
Stimulation of collateral artery growth: travelling further down the road to clinical application
Dr S H Schirmer, Department of Cardiology, Academic Medical Centre, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands; Stephan.schirmer{at}uks.eu Collateral artery growth is a potent natural defence ...
BMJ4d
Rationale and design of a randomised trial of intravenous iron in patients with heart failure
Correspondence to Dr Ian Ford, University of Glasgow Robertson Centre for Biostatistics, Glasgow G12 8QQ, UK; ian.ford{at}glasgow.ac.uk Methods IRONMAN is a prospective, randomised, open-label, ...
BMJ2d
Cardiovascular genetics: the role of genetic testing in diagnosis and management of patients with hypertrophic cardiomyopathy
Correspondence to Dr Carolyn Y Ho, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA 02115, USA; cho{at}bwh.harvard.edu Genetic testing in hypertrophic cardiomyopathy (HCM) is a ...
BMJ5d
Multidisciplinary team approach to heart failure management
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
BMJ3d
14 Time to TAVI: streamlining the outpatient pathway to treatment
Introduction Transcatheter Aortic Valve Implantation (TAVI) is an established treatment option for severe aortic stenosis (AS), with over 5000 procedures performed in the UK in 2019. Given the high ...